Organovo Achieves 3D Tissue Model for Crohn's Disease

Stock Information for Organovo Holdings Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Organovo Holdings Inc.

CORRECTION - Organovo Highlights FXR314 Combination Therapy Potential and Plan
Organovo Highlights FXR314 Combination Therapy Potential and Plan
Organovo to Participate in the H.C. Wainwright Global Investment Conference
Organovo Advances Clinical Timelines for FXR314 and Provides Updates on NASH Phase 2 Data
Organovo Announces FXR Program
Organovo Announces Target Validation Ahead of Schedule, Accelerating Timeline for First Crohn's Disease Drug Candidates
Organovo to Participate in the H.C. Wainwright 24th Annual Global Investment Conference
Organovo Announces Postponement of Annual Meeting of Stockholders

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.